Literature DB >> 20875394

Chemical inhibition of sulfation accelerates neural differentiation of mouse embryonic stem cells and human induced pluripotent stem cells.

Norihiko Sasaki1, Takuya Hirano, Kumiko Kobayashi, Masashi Toyoda, Yoshitaka Miyakawa, Hajime Okita, Nobutaka Kiyokawa, Hidenori Akutsu, Akihiro Umezawa, Shoko Nishihara.   

Abstract

Pluripotency of embryonic stem cells (ESCs) is maintained by the balancing of several signaling pathways, such as Wnt, BMP, and FGF, and differentiation of ESCs into a specific lineage is induced by the disruption of this balance. Sulfated glycans are considered to play important roles in lineage choice of ESC differentiation by regulating several signalings. We examined whether reduction of sulfation by treatment with the chemical inhibitor chlorate can affect differentiation of ESCs. Chlorate treatment inhibited mesodermal differentiation of mouse ESCs, and then induced ectodermal differentiation and accelerated further neural differentiation. This could be explained by the finding that several signaling pathways involved in the induction of mesodermal differentiation (Wnt, BMP, and FGF) or inhibition of neural differentiation (Wnt and BMP) were inhibited in chlorate-treated embryoid bodies, presumably due to reduced sulfation on heparan sulfate and chondroitin sulfate. Furthermore, neural differentiation of human induced pluripotent stem cells (hiPSCs) was also accelerated by chlorate treatment. We propose that chlorate could be used to induce efficient neural differentiation of hiPSCs instead of specific signaling inhibitors, such as Noggin.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875394     DOI: 10.1016/j.bbrc.2010.09.085

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Species-specific developmental timing is maintained by pluripotent stem cells ex utero.

Authors:  Christopher Barry; Matthew T Schmitz; Peng Jiang; Michael P Schwartz; Bret M Duffin; Scott Swanson; Rhonda Bacher; Jennifer M Bolin; Angela L Elwell; Brian E McIntosh; Ron Stewart; James A Thomson
Journal:  Dev Biol       Date:  2017-02-06       Impact factor: 3.582

2.  Glycome diagnosis of human induced pluripotent stem cells using lectin microarray.

Authors:  Hiroaki Tateno; Masashi Toyota; Shigeru Saito; Yasuko Onuma; Yuzuru Ito; Keiko Hiemori; Mihoko Fukumura; Asako Matsushima; Mio Nakanishi; Kiyoshi Ohnuma; Hidenori Akutsu; Akihiro Umezawa; Katsuhisa Horimoto; Jun Hirabayashi; Makoto Asashima
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

3.  Heparan sulfate deficiency in autistic postmortem brain tissue from the subventricular zone of the lateral ventricles.

Authors:  Brandon L Pearson; Michael J Corley; Amy Vasconcellos; D Caroline Blanchard; Robert J Blanchard
Journal:  Behav Brain Res       Date:  2013-01-11       Impact factor: 3.332

Review 4.  Heparan sulfate: a key regulator of embryonic stem cell fate.

Authors:  Daniel C Kraushaar; Stephen Dalton; Lianchun Wang
Journal:  Biol Chem       Date:  2013-06       Impact factor: 3.915

5.  Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State.

Authors:  Mia L Huang; Austen L Michalak; Christopher J Fisher; Mitchell Christy; Raymond A A Smith; Kamil Godula
Journal:  Stem Cells       Date:  2017-10-27       Impact factor: 6.277

Review 6.  Potential for pharmacological manipulation of human embryonic stem cells.

Authors:  Stuart P Atkinson; Majlinda Lako; Lyle Armstrong
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

7.  Embryoid Body-Explant Outgrowth Cultivation from Induced Pluripotent Stem Cells in an Automated Closed Platform.

Authors:  Hiroshi Tone; Saeko Yoshioka; Hirokazu Akiyama; Akira Nishimura; Masaki Ichimura; Masaru Nakatani; Tohru Kiyono; Masashi Toyoda; Masatoshi Watanabe; Akihiro Umezawa
Journal:  Biomed Res Int       Date:  2016-08-28       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.